Cite
Ratschker T, Egenberger L, Alev M, et al. Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells. Pharmaceutics. 2020;12(10)doi: 10.3390/pharmaceutics12100923.
Ratschker, T., Egenberger, L., Alev, M., Zschiesche, L., Band, J., Schreiber, E., Frey, B., Derer, A., Alexiou, C., & Janko, C. (2020). Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells. Pharmaceutics, 12(10), . https://doi.org/10.3390/pharmaceutics12100923
Ratschker, Teresa, et al. "Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells." Pharmaceutics vol. 12,10 (2020). doi: https://doi.org/10.3390/pharmaceutics12100923
Ratschker T, Egenberger L, Alev M, Zschiesche L, Band J, Schreiber E, Frey B, Derer A, Alexiou C, Janko C. Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells. Pharmaceutics. 2020 Sep 27;12(10). doi: 10.3390/pharmaceutics12100923. PMID: 32992645; PMCID: PMC7599695.
Copy
Download .nbib